Cancer is one of the leading causes of morbidity and mortality worldwide. Many patients succumbed to the disease despite best efforts from medical and surgical oncologists. This is because of several challenges like treatment resistance, genetic heterogeneity of tumor cells and high cost of new therapies. It is clear from the recent research that to overcome cancer, a gentler approach is necessary. This approach include controlling inflammatory processes, discovering compounds which can offer minimum resistance from cancer cells, targeting therapy where it is actually needed and increase strength of the patient's body by non-drug ways like exercise and modulating gut microflora. Scientists can help the patients more directly by devising more clinical level studies and publishing results as much as possible, even negative ones (like failure of a novel drug to treat cancer), to avoid loss of precious time and money. A coordinated effort from clinicians, patients and scientists planning studies at clinical level and publication of data, even negative ones can help defeat cancer, even at advanced metastatic stage IV stage.
INTRODUCTION
Cancer is one of the leading causes of morbidity and mortality worldwide, with approximately 14 million new cases in 2012.This number of new cases is expected to rise by about 70% over the next 2 decades. Cancer is the second leading cause of death globally, and was responsible for 8.8 million deaths in 2015. Globally, nearly 1 in 6 deaths are due to cancer and approximately 70% of deaths from cancer occur in low-and middle-income countries. (WHO Cancer Fact sheet February 2018). It is clear from above data that every year, thousands of new cases of cancer are detected and many succumbed to the disease despite best efforts from medical and surgical oncologists. The main reason for the death of cancer patient is extensive spread of cancer throughout the body (metastasis) and multiple organ failure due to it.
Spread of cancer throughout the body (Metastasis):
What we know 1. Metastasis describes a complex process in which cancer cells leave the original tumor place and travel to other parts of the body. This means traditional cancer therapies can act as a 'double-edged sword', the same treatment which is being used to cure cancer can help it in growing. To avoid this unintentional help to cancer growth, a milder approach to tumor is needed.
RD CHALLENGE -CHALLENGES OF FINDING NEW CANCER THERAPIES USING GENETIC INFORMATION:
Cancer usually arises from genomic abnormalities. However, the number and complexity of genetic alterations in tumours can make it difficult to predict whether, and in which tissues, a particular mutation in a specific cancer-linked gene will drive tumour growth. This poses many challenges when trying to identify effective treatments, such as - Suppose a person has a cancer with a particular gene mutation. If we develop a medicine that targets the protein encoded by that gene, could the drug treat another patient who has a different mutation in that 
TH CHALLENGE -DRAWBACKS OF NEW CANCER THERAPIES:
The majority of advanced-stage cancers cannot be cured using the traditional approaches and new treatment strategies are needed. New treatment modalities including immune-checkpoint inhibition, molecularly targeted therapy based on the results of next-generation sequencing, or liquid biopsy-based monitoring for disease recurrence, already have revolutionized the outcomes of patients. However, all approaches are limited in terms of the numbers of patients who can access them. The costs of newly approved agents also remain a major barrier. (Nat. Rev. Clin. Oncol, 2018).
New ways to treat cancer
The message from new research is clear: "Killing cancer cells with more and stronger drugs may backfire. The tumor tissue is a reactive system that turns cell-killing therapy into double-edge swords: the more you kill the more you may stimulate the surviving tumor cells. Therefore, to prevent the or recurrence of treatment-resistant tumors (which is the main reason of cancer treatment failure), we must overcome the debris-induced tumor progression. Researchers are now learning the fact of cancer therapy: Kill the cancer gently. Instead of focusing on harsher and more toxic cancer drugs, a gentle way of killing cancer cells should be followed, such as: (Weintraub PG, 2016) . Publications of such negative results also help in clinicians and patients to choose appropriate therapies, rather than trial and error method, which is likely to waste patient's money and lose precious treatment window time, before it is too late.
CONCLUSION
It is difficult to cure patients with advanced metastatic cancer, but it is not impossible. A coordinated effort from clinicians (giving appropriate therapy at optimum dose), patients (getting healthy diet and appropriate exercise) and scientists (planning studies at clinical level and publication of data, even negative ones) can help defeat cancer, even at advanced metastatic stage IV stage.
